[Cyclosporin A].
D000818:Animals; D001327:Autoimmune Diseases / Q000188:drug therapy; D001402:B-Lymphocytes / Q000187:drug effects; D002490:Central Nervous System / Q000187:drug effects; D003524:Cyclosporins / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D006085:Graft Survival / Q000187:drug effects; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects; D007165:Immunosuppression Therapy; D007668:Kidney / Q000187:drug effects; D016030:Kidney Transplantation; D008232:Lymphoproliferative Disorders / Q000188:drug therapy; D008264:Macrophages / Q000276:immunology; D051379:Mice; D009000:Monocytes / Q000276:immunology; D011955:Receptors, Drug; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D050378:T-Lymphocytes, Regulatory / Q000276:immunology
D003524:Cyclosporins; D011955:Receptors, Drug
Cyclosporin A.